New Clinical Trial Injection of Killer Experimental Viral Virus First Patient
The experimental cancer-killing virus has been successfully introduced to patients for the first time, and it is hoped that the test will eventually reveal evidence of a new tool in the fight against cancer in humans. The drug candidate, called CF33-hNIS (aka Vaxinia), is a genetically modified virus that selectively infects, kills, and maintains healthy …
New Clinical Trial Injection of Killer Experimental Viral Virus First Patient Read More »